Medexus Pharmaceuticals Inc (TSE:MDP) has released an update.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Medexus Pharmaceuticals has successfully concluded negotiations with the pan-Canadian Pharmaceutical Alliance to make Trecondyv, a treosulfan injection, accessible through public drug programs in Canada. This milestone reflects the high demand for Trecondyv in the country and strengthens its market potential. The decision now awaits final approval for public reimbursement by government organizations.
For further insights into TSE:MDP stock, check out TipRanks’ Stock Analysis page.